This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gensler, H. L. Articles by Bowden, G. T. Search for Related Content PubMed PubMed Citation Articles by Gensler, H. L. Articles by Bowden, G. T.

Influence of the Duration of Topical 13-cis-Retinoic Acid Treatment on Inhibition of Mouse Skin Tumor Promotion¹

Department of Radiation Oncology and Cancer Center, University of Arizona Health Sciences Center, Tucson, Arizona 85724

The effect of the time and duration of retinoid treatment on the inhibition of Stage II tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA) was studied in CD-1 mice. All mice were initiated with 400 nmol of benzo(a)pyrene an d received Stage I tumor promotion (3.2 nmol of TPA twice weekly for 2 wk). Animals were then randomized into groups which received 13-cis-retinoic acid during early, middle, or late Stage II promotion. 13-cis-Retinoic acid pretreatments starting on Day 1, Wk 8, or Wk 23 of Stage II promotion resulted in 47, 28, or 19% inhibition, respectively, of TPA-induced tumor formation. One-half of the mice receiving 13-cis-retinoic acid at Day 1 or Wk 8 were removed from the retinoid treatments at Wk 23, the time of cessation of TPA promotion. The inhibition of tumor formation remained constant during the 15-wk observation period after cessation of retinoid treatment, suggesting that retinoid inhibition of mouse skin tumor promotion is stable in the absence of further promotion and preceded the step of irreversible conversion of promoter dependence to promoter independence.

¹ This investigation was supported by NIH Grant CA-27502.

² To whom requests for reprints should be addressed.

Received 9/16/85. Revised 1/23/86. Accepted 3/12/86.

This article has been cited by other articles:

				S. D. Hursting, T. J. Slaga, S. M. Fischer, J. DiGiovanni, and J. M. Phang Mechanism-Based Cancer Prevention Approaches: Targets, Examples, and the Use of Transgenic Mice J Natl Cancer Inst, February 3, 1999; 91(3): 215 - 225. [Abstract] [Full Text] [PDF]